Stay updated on Pembrolizumab for Genomic Instability Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe updates appear to be formatting adjustments and minor text edits without altering core study details such as eligibility criteria or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check41 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check48 days agoChange DetectedUpdated page now shows Revision v3.1.0 and new contact emails/phones; older ovarian cancer-related resources and an older revision v3.0.2 were removed.SummaryDifference0.9%

- Check62 days agoChange DetectedUpdate: Revision changed from v3.0.1 to v3.0.2; removal of the Back to Top element. These are minor UI/metadata changes and do not affect core content, pricing, stock, or time slot information.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%

- Check76 days agoChange DetectedThe page has undergone significant updates, including the addition of new resources related to ovarian cancer and breast cancer, while removing previous references to specific locations and certain genetic disease resources.SummaryDifference5%

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.